Literature DB >> 30080182

Recurrent hypoglycemia inhibits the counterregulatory response by suppressing adrenal activity.

Yunbing Ma, Qian Wang, Debria Joe, Manqi Wang, Matthew D Whim.   

Abstract

Hypoglycemia activates the counterregulatory response (CRR), a neural-endocrine reflex that restores euglycemia. Although effective if occasionally activated, repeated induction of the CRR leads to a decline in responsiveness and prolonged exposure to hypoglycemia. The mechanism underlying this impairment is not known. We found that the reduction in epinephrine release that characterizes a suppressed CRR involves a long-lasting form of sympatho-adrenal synaptic plasticity. Using optogenetically evoked catecholamine release, we show that recurrent hypoglycemia reduced the secretory capacity of mouse adrenal chromaffin cells. Single activation of the CRR increased the adrenal levels of tyrosine hydroxylase (TH), the rate-limiting enzyme for catecholamine synthesis, but this was prevented by repeated activation. In contrast, the level of neuropeptide Y (NPY), an adrenal cotransmitter, remained elevated after recurrent hypoglycemia. Inhibition of NPY or Y1 signaling, either transgenically or pharmacologically, prevented the attenuation of both TH expression and epinephrine release. These results indicate that impairment of the CRR involves suppressed activity at the adrenal level. Interfering with the peripheral NPY-dependent negative feedback loop may provide a way to avoid the pathophysiological consequences of recurrent hypoglycemia which are common in the diabetic state.

Entities:  

Keywords:  Diabetes; Neuroscience

Mesh:

Substances:

Year:  2018        PMID: 30080182      PMCID: PMC6118578          DOI: 10.1172/JCI91921

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Recurrent hypoglycemia reduces the glucose sensitivity of glucose-inhibited neurons in the ventromedial hypothalamus nucleus.

Authors:  Zhentao Song; Vanessa H Routh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-06-22       Impact factor: 3.619

2.  Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia.

Authors:  N C Tkacs; A A Dunn-Meynell; B E Levin
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

Review 3.  Effects of insulin per se on neuroendocrine and metabolic counter-regulatory responses to hypoglycaemia.

Authors:  P Galassetti; S N Davis
Journal:  Clin Sci (Lond)       Date:  2000-11       Impact factor: 6.124

4.  Celiac-superior mesenteric ganglionectomy, but not vagotomy, suppresses the sympathoadrenal response to insulin-induced hypoglycemia.

Authors:  Satoshi Fujita; Casey M Donovan
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

5.  Neuropeptide y gates a stress-induced, long-lasting plasticity in the sympathetic nervous system.

Authors:  Qian Wang; Manqi Wang; Matthew D Whim
Journal:  J Neurosci       Date:  2013-07-31       Impact factor: 6.167

6.  Repeated 2-deoxy-D-glucose-induced glucoprivation attenuates Fos expression and glucoregulatory responses during subsequent glucoprivation.

Authors:  N M Sanders; S Ritter
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

7.  Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious dogs.

Authors:  R T Frizzell; G K Hendrick; D W Biggers; D B Lacy; D P Donahue; D R Green; R K Carr; P E Williams; R W Stevenson; A D Cherrington
Journal:  Diabetes       Date:  1988-06       Impact factor: 9.461

8.  Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans.

Authors:  S R Heller; P E Cryer
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461

9.  Posttranscriptional regulation of adrenal TH gene expression contributes to the maladaptive responses triggered by insulin-induced recurrent hypoglycemia.

Authors:  Necla Kudrick; Owen Chan; Edmund F La Gamma; Juhye Lena Kim; Arnold William Tank; Carol Sterling; Bistra B Nankova
Journal:  Physiol Rep       Date:  2015-02-22

10.  A parabrachial-hypothalamic cholecystokinin neurocircuit controls counterregulatory responses to hypoglycemia.

Authors:  Alastair S Garfield; Bhavik P Shah; Joseph C Madara; Luke K Burke; Christa M Patterson; Jonathan Flak; Rachael L Neve; Mark L Evans; Bradford B Lowell; Martin G Myers; Lora K Heisler
Journal:  Cell Metab       Date:  2014-12-02       Impact factor: 27.287

View more
  7 in total

1.  Evaluation of Clinical Metrics for Identifying Defective Physiologic Responses to Hypoglycemia in Long-Standing Type 1 Diabetes.

Authors:  Anneliese J Flatt; Elizabeth Chen; Amy J Peleckis; Cornelia Dalton-Bakes; Huong-Lan Nguyen; Heather W Collins; John S Millar; Robert J Gallop; Michael R Rickels
Journal:  Diabetes Technol Ther       Date:  2022-07-26       Impact factor: 7.337

Review 2.  Central Mechanisms of Glucose Sensing and Counterregulation in Defense of Hypoglycemia.

Authors:  Sarah Stanley; Amir Moheet; Elizabeth R Seaquist
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

3.  Beyond the brain: do peripheral mechanisms develop impaired awareness of hypoglycemia?

Authors:  Elizabeth R Seaquist
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

4.  Repetitive hypoglycemia reduces activation of glucose-responsive neurons in C1 and C3 medullary brain regions to subsequent hypoglycemia.

Authors:  Zohra M Kakall; Mary M Kavurma; E Myfanwy Cohen; Peter R Howe; Polina E Nedoboy; Paul M Pilowsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-04-23       Impact factor: 4.310

5.  A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study.

Authors:  Simon R Heller; Milan S Geybels; Ahmed Iqbal; Lei Liu; Lily Wagner; Elaine Chow
Journal:  Diabetologia       Date:  2021-10-26       Impact factor: 10.122

6.  USE OF A CONTINUOUS GLUCOSE MONITOR FOR PREOPERATIVE MONITORING AND TREATMENT OF HYPOGLYCEMIA IN A CASE OF PANCREATIC NEUROENDOCRINE TUMOR.

Authors:  Ryan C Lyerla; Arrsh Bajaj; Rupendra T Shrestha
Journal:  AACE Clin Case Rep       Date:  2019-06-07

Review 7.  Integrating the inputs that shape pancreatic islet hormone release.

Authors:  Glyn M Noguchi; Mark O Huising
Journal:  Nat Metab       Date:  2019-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.